Ibuprofen /kg
ApprovedSmall molecule
Ibuprofen /kg is one of 62 small molecule programs targeting Pulpitis. It is currently in Approved.
2
Indications
2
Total Trials
0
Active Trials
61
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
357 competitors in Migraine
#DrugCompanyPhaseTrials
1Ibuprofen /kg
IInonu University
Approved
Aimovig
AmgenPreclinical
Emgality
Eli LillyPreclinical
Bayer Aspirin
BayerPreclinical
Savella
AbbViePreclinical
Cervidil
PfizerPreclinical
Botox
RRevance Therapeutics, Inc.
Preclinical
Adempas
BayerPreclinical
Viagra
VViatris Specialty LLC
Preclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Ibuprofen /kg. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- IInonu University